P100022S033

None

FDA Premarket Approval P100022 S033

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP100022S033
Classification NameNone
Applicant
PMAP100022
SupplementS033

Supplemental Filings

Supplement NumberDateSupplement Type
P100022Original Filing
S034 2019-09-03 Special (immediate Track)
S033
S032 2018-12-26 Real-time Process
S031 2018-10-11 30-day Notice
S030 2018-10-09 Normal 180 Day Track No User Fee
S029 2018-08-09 30-day Notice
S028 2018-08-01 30-day Notice
S027 2018-05-29 Normal 180 Day Track
S026 2017-10-30 Normal 180 Day Track
S025 2017-06-01 Real-time Process
S024 2017-03-13 30-day Notice
S023 2017-03-07 30-day Notice
S022 2017-03-03 Real-time Process
S021 2016-11-18 Special (immediate Track)
S020 2016-07-05 Panel Track
S019
S018 2016-06-02 30-day Notice
S017 2016-03-15 30-day Notice
S016 2015-07-24 135 Review Track For 30-day Notice
S015 2015-07-15 Special (immediate Track)
S014 2015-06-18 Normal 180 Day Track
S013 2015-03-17 Normal 180 Day Track No User Fee
S012 2015-02-02 30-day Notice
S011 2014-11-12 Normal 180 Day Track No User Fee
S010 2014-04-17 Normal 180 Day Track No User Fee
S009 2013-09-20 30-day Notice
S008 2013-07-22 Real-time Process
S007 2013-06-24 30-day Notice
S006 2013-06-19 Special (immediate Track)
S005
S004 2012-12-13 Normal 180 Day Track No User Fee
S003 2012-12-13 Normal 180 Day Track No User Fee
S002 2012-12-11 Normal 180 Day Track
S001 2012-12-03 Normal 180 Day Track

© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.